Metal Ions Catalytic for Free Radical Reactions in the Plasma of Patients with Fulminant Hepatic Failure

References

• Williams R. Management of acute liver failure. Postgraduate Medical Journal 1988; 64: 679–771
   Google Scholar
• Capocaccia L., Angelico M. Fulminant hepatic failure. Digestive Diseases and Science 1991; 36: 775–779
   Google Scholar
• Manns M. P. New therapeutic aspects in fulminant hepatic failure. Chest 1991; 100: 193S–196S
   Google Scholar
• Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). European Journal of Biochemistry 1990; 192: 245–261
   PubMedGoogle Scholar
• Huber M., Heppler D. Eicosanoids and liver. Progress in Liver Diseases, H. Popper, F. Schaffner. Saunders, Philadelphia 1990; 9: 117–141
   Google Scholar
• Harris E. D. Copper transport: an overview. Proceedings of the Society for Experimental Biology and Medicine 1991; 146: 130–140
   Google Scholar
• Aisen P. Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin. Annals of Neurology 1992; 32: S62–S68
   Web of Science ®Google Scholar
• Brissot P., Wright T. L., Ma W. L., Weisiger R. A. Efficient clearance of non-transferrin-bound iron by rat liver. Journal of Clinical Investigation 1985; 76: 1463–1470
   PubMed Web of Science ®Google Scholar
• Craven C. M., Alexander J., Eldridge M., Kushner J. P., Bernstein S., Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: A rodent model for hemochromatosis. Proceedings of the National Academy of Sciences of the USA 1987; 84: 3457–3461
   PubMed Web of Science ®Google Scholar
• Wright T. L., Brissot P., Ma W. L., Weisiger R. A. Characterization of non-transferrin-bound iron clearance by rat liver. Journal of Biological Chemistry 1986; 261: 10909–10914
   PubMedGoogle Scholar
• Halliwell B., Aruoma O. I., Mufti G., Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. FEBS Letters 1988; 241: 202–204
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M.C. Free Radicals in Biology and Medicine, 2nd edn. Clarendon Press, Oxford 1989
   Google Scholar
• Aruoma O. I., Bomford A., Poison R. J., Halliwell B. Non-transferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 1988; 72: 1416–1419
   PubMedGoogle Scholar
• Gutteridge J. M.C., Halliwell B. Radical-promoting loosely-bound iron in biological fluids and the bleomycin assay. Life Chemistry Reports 1987; 4: 113–142
   Google Scholar
• Gutteridge J. M.C., Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of “free” iron in biological systems by using bleomycin-dependent degradation of DNA. Biochemical Journal 1981; 199: 263–265
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M.C. The antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics 1990; 280: 1–8
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C., Stocks J. Caeruloplasmin, physiological and pathological perspectives. CRC Critical Reviews in Clinical Laboratory Science 1981; 14: 257–329
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C. Copper-phenanthroline induced site-specific oxygen radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochemical Journal 1984; 218: 983–985
   PubMed Web of Science ®Google Scholar
• Evans P. J., Bomford A., Halliwell B. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease. Free Radical Research Communications 1989; 7: 55–62
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Evans R. W., Williams J. Studies on the binding of different iron donors to human serum transferrin and isolation of iron-binding fragments from the N-and C-terminal regions of the protein. Biochemical Journal 1978; 173: 543–552
   Google Scholar
• Aruoma O. I., Halliwell B., Laughton M. J., Quinlan G. J., Gutteridge J. M.C. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an Fe(II)/Fe(III) complex. Biochemical Journal 1989; 258: 617–620
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C., Rowley D. A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clinical Science 1985; 68: 463–467
   PubMed Web of Science ®Google Scholar
• Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 1992; 286: 901–905
   PubMed Web of Science ®Google Scholar
• Friedl H. P., Smith D. J., Till G. O., Thomson P. D., Louis D. S., Ward P. A. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. American Journal of Pathology 1990; 136: 491–495
   PubMed Web of Science ®Google Scholar
• Bautista A. P., Schuler A., Spoiarics Z., Spitzer J. J. Tumor necrosis factor-a stimulates superoxide anion generation by perfused rat liver and Kupffer cells. American Journal of Physiology 1991; 261: G891–G895
   PubMedGoogle Scholar
• Ringer B., Pichlmayr R., Lubber N., Borroscheuer A., Kuse E. Total hepatectomy as temporary approach to acute hepatic or primary graft failure. Transplantation Proceedings, XX(suppl. 1)552–557
   Google Scholar
• Halliwell B. Drug antioxidant effects. A basis for drug selection?. Drugs 1991; 42: 569–605
   PubMed Web of Science ®Google Scholar